Could a stomach bug fuel bile duct cancer?
NCT ID NCT06909188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out if certain Helicobacter bacteria (like H. pylori) are more common in people with biliary tract cancer than in those with non-cancerous gallbladder issues. Researchers will test tissue samples from 250 participants, including cancer patients, people with benign gallbladder disease, and healthy liver donors. The goal is to see if these bacteria might play a role in cancer development.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ILBS
RECRUITINGNew Delhi, National Capital Territory of Delhi, 110070, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
- New drug cocktail aims to outperform standard immunotherapy in bile duct cancer
- Liver cancer registry aims to uncover new biomarkers from thousands of patients
- Triple-Drug cocktail targets Hard-to-Treat biliary cancers